aclacinomycin has been researched along with vindesine in 2 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (vindesine) | Trials (vindesine) | Recent Studies (post-2010) (vindesine) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 1,299 | 422 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masaoka, T | 1 |
| Gahrton, G | 1 |
1 review(s) available for aclacinomycin and vindesine
| Article | Year |
|---|---|
Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Age Factors; Aminoacridines; Amsacrine; Anthraquinones; Antibodies, Monoclonal; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Infant; Interferons; Leukemia; Leukemia, Lymphoid; Liposomes; Middle Aged; Mitoxantrone; Naphthacenes; Prognosis; Teniposide; Transplantation, Homologous; Transplantation, Isogeneic; Vinblastine; Vindesine | 1983 |
1 other study(ies) available for aclacinomycin and vindesine
| Article | Year |
|---|---|
[Present status of the multidisciplinary treatment of acute leukemia].
Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Doxorubicin; Humans; Leukemia; Naphthacenes; Vincristine; Vindesine | 1985 |